Recent NGS screening in different types of advanced tumors, including ovarian cancer, highlighted the presence of FBXW7 mutations that occurred in isolation (12%) or, more frequently (88%), with a concomitant aberration in one or two genes [46]. This evidence concerns the gene FBXW7 and ovarian carcinoma.